CION Ameerpet
If your mother, sister or daughter has had breast cancer, your own risk is roughly doubled — and higher still if more than one close relative was affected or they were diagnosed young. But family history is not destiny: most women with an affected relative never develop breast cancer, and most breast cancers occur in women with no family history at all. At CION, a woman-headed, tumor-board-led team helps you understand your real risk, decide if genetic testing makes sense, and set up the right breast cancer screening — without rushed decisions or unnecessary tests.
Having a close relative with breast cancer does raise your risk — but usually by less than people fear. A single first-degree relative (your mother, sister or daughter) with breast cancer roughly doubles your own risk. If two first-degree relatives have been affected, the risk rises to about three to five times the average. The risk climbs further when a relative was diagnosed young (under 50), when the same person had cancer in both breasts, or when breast cancer appears alongside ovarian, pancreatic or prostate cancer in the family.
Two facts should reassure you. First, most breast cancers — around 70-80% — occur in women with no family history at all. Second, only about 5-10% of breast cancers are caused by a clearly inherited faulty gene. So a worrying family history is a reason to assess your risk carefully and screen smartly — not a reason to assume the worst.
One first-degree relative (mother, sister, daughter) with breast cancer roughly doubles your lifetime risk compared with a woman who has none.
Two affected first-degree relatives raise the risk to roughly three to five times average — and a clearly inherited gene becomes more likely.
Most women who develop breast cancer have no affected relative — which is why screening matters for everyone, not only high-risk families.
Only about 5-10% of breast cancers are caused by a clearly inherited gene fault such as BRCA1 or BRCA2 — and roughly 70-80% of breast cancers occur in women with no family history at all. A worrying family history is a reason to assess your risk and screen smartly, not a reason to assume the worst. Source: NCCN guidelines / SEER.
Not every family history carries the same weight. A grandmother diagnosed in her 80s is very different from a mother and aunt diagnosed in their 40s. Oncologists look less at the simple count of affected relatives and more at the pattern — how close the relatives are to you, how young they were, and whether other related cancers appear. The features below are the ones that most increase the chance of an inherited gene and that should prompt a specialist risk review.
Mother, sister or daughter affected carries far more weight than a cousin or great-aunt. Second-degree relatives (grandmother, aunt, niece) still add to risk, especially when several are affected on the same side.
A relative diagnosed before 50 — and especially before 40 — is a strong signal. Early-onset disease is more likely to be driven by an inherited gene such as BRCA1 or BRCA2.
Breast cancer in any male relative — father, brother, uncle, grandfather — is an important red flag, because male breast cancer is strongly linked to inherited BRCA2 mutations. Even one case warrants a genetics review.
Breast and ovarian cancer in the same family (or the same person) point strongly to a BRCA mutation. Pancreatic and aggressive prostate cancer in the family add to that picture.
A relative who had cancer in both breasts (bilateral), or both breast and ovarian cancer, raises the likelihood of a hereditary cause.
A common and costly myth is that breast cancer risk only passes down through your mother's side. It does not. The main breast cancer genes — BRCA1 and BRCA2 — are inherited equally from either parent. If your father carries a BRCA mutation, you have a 50% chance of inheriting it, exactly as you would from your mother. Because men with a BRCA mutation usually don't develop breast cancer themselves, a strong hereditary risk can travel silently down the father's side for generations and be missed.
This is one area where many Indian websites fall short — they focus only on the mother's family. When we take your history at CION, we deliberately map both sides of the family, going back three generations where possible, so an inherited risk hiding on your father's side is not overlooked.
BRCA1 and BRCA2 mutations are inherited equally from mothers and fathers. A father can carry and pass on a high-risk gene without ever developing breast cancer himself.
If a parent carries a BRCA mutation, each child — son or daughter — has a 50% chance of inheriting it. Inheriting it does not mean you will get cancer, but it does change your screening plan.
On your father's side, look at his mother, sisters and their daughters. Several breast or ovarian cancers there are just as significant as on your mother's side.
A proper risk assessment records cancers on both sides, the type of cancer, and the age at diagnosis — the detail that decides whether genetic testing is worthwhile.
Worry about a family history is its own kind of burden — and it deserves a careful, unhurried answer, not a quick brush-off or a pile of tests you don't need. CION is a woman-headed, tumor-board-led organisation built for exactly these conversations: honest about your real risk, clear about what testing can and can't tell you, and transparent on cost.
17 super-specialist oncologists across medical, surgical and radiation oncology, working as one panel — so your risk and any testing are interpreted by experts, not guesswork.
We take a full, three-generation family history on both sides and explain your risk in plain language — no jargon, no unnecessary tests.
Genetic testing is offered when it will genuinely change your plan — and we explain what a positive, negative or uncertain result really means before you decide.
A 4.8/5 Google rating across centres in Telangana and AP, with up to 50% discounts on diagnostics and a free first consultation for all cancer patients and concerned families.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Woman-led, tumor-board-reviewed, confidential care across 35+ centres in Telangana & AP. Call 1800-202-8726.
Genetic testing looks for an inherited fault in genes such as BRCA1, BRCA2, PALB2, TP53, CHEK2 and ATM. It is not for everyone — for most women with a single, older relative, the result wouldn't change anything. But for women whose family history fits a hereditary pattern, a test can be life-changing: a woman who inherits a BRCA1 or BRCA2 mutation can carry up to a 7-in-10 (about 70%) lifetime risk of breast cancer, and knowing that allows for far earlier, more intensive surveillance and prevention.
The right path usually starts with genetic counselling — a session where a specialist reviews your family tree and decides whether testing is worthwhile, who in the family should be tested first, and how to read the result. Where possible, an affected relative is tested first, because a clear answer in them makes your own result far easier to interpret. At CION, we follow NCCN-aligned criteria so testing is recommended only when it can genuinely guide your care.
Especially under 40 — early-onset breast cancer in a mother, sister or daughter is one of the strongest reasons to consider genetic counselling and testing.
Multiple breast cancers on one side of the family — particularly first-degree relatives, or relatives across two or more generations — point toward an inherited gene.
A family with both breast and ovarian cancer, or any male breast cancer, meets criteria for BRCA testing regardless of how many relatives are affected.
If a relative has already tested positive for a BRCA or other high-risk mutation, you can be tested specifically for that single change — a simpler, more definitive test.
Certain ancestries carry a higher chance of particular BRCA mutations, lowering the threshold for testing when combined with any family history.
The biggest practical benefit of knowing your family risk is that it lets you screen earlier and more thoroughly than the general population. Routine breast screening usually begins at 40, but women at moderate or high risk should not wait that long. The exact plan depends on your assessed risk level — and on whether a high-risk gene has been confirmed — but the principle is the same: find any cancer at its smallest, most curable stage.
For women at high risk, the gold standard is an annual breast MRI alongside mammography, often starting in the 30s or roughly 10 years before the age at which your youngest affected relative was diagnosed. MRI is the most sensitive test, particularly in the dense breasts common in younger Indian women. At CION, the tumor board sets your screening interval and tests so you are neither under-screened nor over-tested.
Whatever your risk level, monthly breast self-awareness is your front line — report any new lump, skin change, or nipple change promptly rather than waiting for the next scan.
Women at moderate risk are typically offered mammography screening from age 40 — sometimes earlier — rather than waiting for any national programme.
Confirmed high-risk women (a known BRCA mutation or strong family history) are usually offered yearly breast MRI alongside mammography, often from their 30s, because MRI detects cancers mammography can miss in dense breasts.
A common rule of thumb is to begin enhanced screening about a decade before the age at which your youngest first-degree relative was diagnosed — so a mother diagnosed at 42 might mean screening from your early 30s.
Where MRI isn't suitable, breast ultrasound adds sensitivity in dense tissue and uses no radiation — useful for younger women under regular surveillance.
If your assessment — or a positive genetic test — places you at high risk, there is more you can do than screen and wait. Risk-reduction options range from simple lifestyle changes that benefit everyone, to preventive medication, to risk-reducing surgery for the small number of women with a confirmed high-risk gene. None of these is a decision to rush; each is weighed carefully with your oncologist against your personal risk, age and plans for a family.
The right choice is deeply individual. At CION, these options are discussed by the full tumor board and explained honestly — including what each can and cannot achieve — so the decision is yours, made for healing and peace of mind rather than fear.
Keeping a healthy weight, staying physically active, limiting alcohol, not smoking, and breastfeeding where possible each modestly lower breast cancer risk — and benefit your whole health.
For some women at moderate-to-high risk, hormone-blocking medicines (such as tamoxifen or an aromatase inhibitor) can reduce the chance of developing hormone-sensitive breast cancer. This is decided individually, weighing benefit against side effects.
For a small number of women with a confirmed BRCA mutation, preventive (prophylactic) mastectomy substantially lowers breast cancer risk, and removing the ovaries can lower both ovarian and breast cancer risk. These are major, personal decisions taken only after full counselling.
For most high-risk women, intensive screening rather than surgery is the right path — with a clear plan reviewed regularly as guidelines and your situation evolve.
If breast cancer runs in your family and you're not sure what it means for you, you don't have to carry that worry alone or work it out from internet searches. CION offers a clear, woman-led pathway — from a free first consultation to a personalised screening plan — so you leave with answers and a plan, not more anxiety.
A specialist takes a full, three-generation family history on both sides, examines you if needed, and explains your real risk in plain language — no pressure, no unnecessary tests.
If your history meets the criteria, we explain BRCA and panel testing — who to test first, what each result means, and the cost — before you decide anything.
We set exactly the right schedule for you — mammography, MRI or ultrasound, starting at the right age — with up to 50% discounts on diagnostics.
Your plan is reviewed by the tumor board and updated over time, with nutrition and psycho-oncology support if the worry is weighing on you — care led by a team, not one doctor.
And should anything ever need treatment, our outcomes speak for themselves: CION's 1-year survival rate for breast cancer is 96.9%, compared with the national average of 85.4% — an advantage of +11.5 percentage points.* For the overwhelming majority of women with a family history, though, the path is simply earlier screening and peace of mind. Call us on 1800-202-8726 or book a free consultation online.
*1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP). CION figures are network outcomes; national figures are population averages and do not predict an individual's result.
Hear from women who came to CION worried about a family history — and the clarity and plan they walked away with.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.If your mother (a first-degree relative) had breast cancer, your own risk is roughly doubled compared with a woman who has no family history. That sounds alarming, but it still means most women in your position never develop breast cancer. Your actual risk depends on the detail: how old your mother was when diagnosed (under 50 raises concern), whether other relatives on either side were also affected, and whether any ovarian or male breast cancer appears in the family. A specialist can take your full family history and tell you your real, personalised risk — and whether genetic testing or earlier screening would help. At CION, that first consultation is free.
Yes. A sister with breast cancer is a first-degree relative, so your risk is roughly doubled — similar to having an affected mother. The concern is greater if your sister was diagnosed young (under 50), if she had cancer in both breasts, or if other relatives have had breast or ovarian cancer. Because a shared gene is possible, it can be worth your sister having genetic testing first: if she carries a BRCA or other high-risk mutation, you can be tested specifically for that single change, which gives a far clearer answer. A specialist risk review will tell you whether testing and earlier screening make sense in your case.
No — this is a common myth. The main breast cancer genes, BRCA1 and BRCA2, are inherited equally from either parent. If your father carries a mutation, you have a 50% chance of inheriting it, exactly as you would from your mother. Because men with these mutations usually don't develop breast cancer themselves, a high-risk gene can pass silently down the father's side and be missed. That's why a proper assessment maps both sides of the family. Pay particular attention to your father's mother, sisters and their daughters, and to any breast, ovarian or male breast cancer on that side.
It's the pattern, not just the number. One first-degree relative (mother, sister, daughter) roughly doubles your risk; two raises it to about three to five times average. But a single relative diagnosed before 40, any male breast cancer, or breast plus ovarian cancer in the family can each signal an inherited gene even without many cases. A 'strong' family history typically means two or more close relatives on the same side, relatives diagnosed young, cancer in both breasts, or breast and ovarian cancer together. If any of these describe your family, a specialist risk review is worthwhile.
Genetic testing is worth considering when your family history fits a hereditary pattern: a first-degree relative diagnosed under 50, two or more relatives on the same side, breast and ovarian cancer in the family, any male breast cancer, or a relative who already tested positive for a BRCA mutation. Certain ancestries lower the threshold further. Testing usually begins with genetic counselling, where a specialist decides whether it will actually change your plan and who should be tested first — ideally an affected relative. A BRCA1 or BRCA2 mutation can carry up to a 70% lifetime breast cancer risk, so a clear result allows much earlier screening and prevention. At CION we follow NCCN-aligned criteria.
Earlier than the usual age of 40. Women at moderate risk are typically offered mammography from 40, sometimes sooner. Women at high risk — a known BRCA mutation or a strong family history — are usually offered annual breast MRI alongside mammography, often starting in their 30s. A widely used rule of thumb is to begin enhanced screening about 10 years before the age at which your youngest first-degree relative was diagnosed; so a mother diagnosed at 42 might mean screening from your early 30s. MRI is the most sensitive test, especially in the dense breasts common in younger Indian women. A specialist will set the exact plan for your risk level.
Yes, to varying degrees. Everyone benefits from lifestyle steps — a healthy weight, regular activity, limiting alcohol, not smoking, and breastfeeding where possible all modestly lower risk. For some women at moderate-to-high risk, hormone-blocking medication (such as tamoxifen or an aromatase inhibitor) can reduce the chance of hormone-sensitive breast cancer. For the small number with a confirmed high-risk gene, risk-reducing surgery is an option discussed carefully with the team. For most women, though, the most valuable step is earlier, more intensive screening so anything that does develop is caught at its most curable stage. A specialist can tailor the right mix for you.
No. A family history raises your risk but does not make breast cancer certain — most women with an affected close relative never develop it. Only about 5-10% of breast cancers are caused by a clearly inherited faulty gene, and 70-80% of all breast cancers occur in women with no family history at all. Even a confirmed BRCA mutation means a higher risk, not a guarantee. The value of knowing your family history is that it lets you screen earlier and consider prevention, turning anxiety into a clear, manageable plan. A CION specialist can give you your real numbers and the next steps that fit your situation.
Yes. CION offers a free first consultation for all cancer patients and for families worried about their risk. It is a full 45-minute session in which a specialist takes a detailed family history from both sides, going back three generations where possible, and explains your real risk in plain language. If your history meets the criteria, we explain genetic counselling and BRCA testing — including what each result means and the cost — before you decide anything. We then set a personalised screening plan with up to 50% discounts on diagnostics. You can book on 1800-202-8726 or request a callback through the form on this page.